Evidence map›Paper›PMID 30575336›Full record

GuidelineJournal of hepato-biliary-pancreatic sciences2019

Clinical practice guidelines for IgG4-related sclerosing cholangitis.

Terumi Kamisawa, Takahiro Nakazawa, Susumu Tazuma, Yoh Zen, Atsushi Tanaka, Hirotaka Ohara, Takashi Muraki, Kazuo Inui, Dai Inoue, Takayoshi Nishino and 17 more

Open access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in Journal of hepato-biliary-pancreatic sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 4 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 4 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Guideline
  2. [Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Guideline
  3. Guideline
  4. [Surgical approach to benign bile duct alterations].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2020
    Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 1 country.

Terumi KamisawaDepartment of Internal Medicine, Tokyo Metropolitan, Komagome Hospital, Tokyo, Japan.
Takahiro NakazawaDepartment of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Susumu TazumaDepartment of General Internal Medicine, Hiroshima University Graduate School of Biomedical & Health Science, Hiroshima, Japan.
Yoh ZenDepartment of Diagnostic Pathology, Kobe University, Kobe, Japan.
Atsushi TanakaDepartment of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Hirotaka OharaDepartment of Community-Based Medical Education, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Takashi MurakiDepartment of Medicine, Gastroenterology, Shinshu University, Matsumoto, Nagano, Japan.
Kazuo InuiDepartment of Gastroenterology, Second Teaching Hospital, Fujita Health University, Nagoya, Japan.
Dai InoueDepartment of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Takayoshi NishinoDepartment of Gastroenterology, Tokyo Womens' Medical University Yachiyo Medical Center, Yachiyo, Japan.
Itaru NaitohDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Takao ItoiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Kenji NotoharaDepartment of Anatomic Pathology, Kurashiki Central Hospital, Kurashiki, Japan.
Atsushi KannoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kensuke KubotaDepartment of Endoscopy, Yokohama City University Hospital, Yokohama, Japan.
Kenji HiranoDepartment of Gastroenterology, Tokyo Takanawa Hospital, Tokyo, Japan.
Hiroyuki IsayamaDepartment of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Kyoko ShimizuDepartment of Gastroenterology, Tokyo Womens' Medical University, Tokyo, Japan.
Toshio TsuyuguchiEndoscopy Center, Chiba University Hospital, Chiba, Japan.
Tooru ShimosegawaDivision of Gastroenterology, South-Miyagi Medical Center, Ohgawara, Japan.
Shigeyuki KawaDepartment of Internal Medicine, Matsumoto Dental University, Matsumoto, Japan.
Tsutomu ChibaKansai Electric Power Hospital, Osaka, Japan.
Kazuichi OkazakiThe Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Moriguchi, Japan.
Hajime TakikawaDepartment of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Wataru KimuraFaculty of Medicine, Departments of Gastroenterology and Gastroenterological, General, Breast, and Thyroid Surgery, Yamagata University, Yamagata, Japan.
Michiaki UnnoDivision of Hepato-Biliary Pancreatic Surgery, Tohoku University Graduate School, of Medicine, Sendai, Japan.
Masahiro YoshidaDepartment of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, School of Medicine, International University of Health and Welfare, Ichikawa, Japan.
Nagoya City University · JPTeikyo University · JPTohoku University · JPTokyo Women's Medical University · JPChiba University Hospital · JPFujita Health University Hospital · JPHiroshima University · JPInternational University of Health and Welfare · JPJapanese Red Cross Nagoya Daini Hospital · JPJuntendo University · JPKanazawa University · JPKansai Electric Power Hospital · JPKansai Medical University · JPKobe University · JPKurashiki Central Hospital · JPMatsumoto Dental University · JPShinshu University · JPTochigi Medical Center · JPTokyo Medical University · JPTokyo Metropolitan Komagome Hospital · JP

Funding

Ministry of Health, Labor, and Welfare of Japan
6 · The paper itself

Abstract

IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria of IgG4-SC were established in 2012, differential diagnosis from primary sclerosing cholangitis and cholangiocarcinoma is sometimes difficult. Furthermore, no practical guidelines for IgG4-SC are available. Because the evidence level of most articles retrieved through searching the PubMed, Cochrane Library, and Igaku Chuo Zasshi databases was below C based on the systematic review evaluation system of clinical practice guidelines MINDS 2014, we developed consensus guidelines using the modified Delphi approach. Three committees (a guideline creating committee, an expert panelist committee for rating statements according to the modified Delphi method, and an evaluating committee) were organized. Eighteen clinical questions (CQs) with clinical statements were developed regarding diagnosis (14 CQs) and treatment (4 CQs). Recommendation levels for clinical statements were set using the modified Delphi approach. The guidelines explain methods for accurate diagnosis, and safe and appropriate treatment of IgG4-SC.

Indexed as

AlgorithmsAutoimmune DiseasesCholangitis, SclerosingDelphi TechniqueHumansImmunoglobulin GImmunoglobulin GBile ductGuidelineIgG4Sclerosing cholangitisSteroid

Identifiers

PMID30575336
PMCPMC6590186
OpenAlexW2906062130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.